RIPK1 and central nervous system cancer: ZZW-115, an antitumor agent that triggers both apoptosis and necroptosis, and citronellol, a natural compound that promotes RIPK1/RIPK3-dependent necroptosis [42, 43], were tested in U251 and U87 glioma lines (Fig. 5A–C).